Featured Posts

To top
Title Image

IPO Tag

30 May

Glossier on the IPO Path

Glossier on the IPO Path
The stage is about for a Glossier IPO. With a fresh round of funding and sky-high valuation, Glossier’s debut on the general public markets seems more an issue of when, not if. The quintessential Millennial beauty business just accomplished its third round of funding — $52 million — valuing the business at about $390 million, based on industry sources. The raise follows a $24 million Series B in late 2016, and $8.4 million Series A in 2014. The investments and the valuation are major for a business that beauty sources say shouldn't be yet profitable and that has an estimated $40 million in sales. Weiss said in an e-mail to Glossier subscribers that the brand new capital will keep the corporate doing “more...
Continue reading
26 Mar

Glossier Potential IPO, Merit Potential Sale Kick Off Makeup

Glossier Potential IPO, Merit Potential Sale Kick Off Makeup
Industry speculation that makeup can be 2024’s hottest M&A goal is quickly becoming a reality. The category, now years right into a post-pandemic rebound and still prestige beauty’s largest segment within the U.S., has seen a plethora of entrants — most of whom have grown each the general pie and their slices of it — exploring exit options. Industry sources told WWD that Glossier, roughly a 12 months after its Sephora debut, has hired Morgan Stanley to explore options, including an initial public offering. Sources also say they’re not alone — Merit Beauty has reportedly tapped Goldman Sachs because it looks at a possible sale. Glossier, Merit and Morgan Stanley declined to comment. Goldman Sachs didn't immediately reply to requests for comment. Products from Merit. Makeup...
Continue reading
25 Mar

Douglas Group Plans for IPO

Douglas Group Plans for IPO
PARIS — Douglas Group said Monday that it plans a public listing on the regulated market of the Frankfurt Stock Exchange as early as March 2024, subject to capital market conditions. The Düsseldorf, Germany-based beauty retailer targets an equity contribution of around 1.1 billion euros, including the targeted IPO primary proceeds and an added equity injection of around 300 million euros from the present shareholders, it said in an announcement.  Group shareholders include Kirk Beauty International SA, the holding company majority owned by funds advised by CVC Capital Partners and the Kreke family. IPOs are heating up within the European beauty market, with Puig and reportedly Galderma mulling public offers. “The proceeds are expected for use to proceed deleveraging the Douglas Group’s balance sheet,” the corporate...
Continue reading
25 Apr

Johnson & Johnson Prepares IPO for Its Consumer Health

Johnson & Johnson Prepares IPO for Its Consumer Health
Johnson & Johnson plans to launch an initial public offering for Kenvue Inc., a completely owned subsidiary comprising its Consumer Health business, later this 12 months. The corporate goals to lift as much as $3.5 billion within the IPO, which comes at a time of muted public offerings within the U.S. J&J’s Consumer Health activity involves self care, skin health and sweetness, and essential health brands, including Neutrogena, Aveeno, Dr. Ci:Labo, NeoStrata, OGX, Dabao and Le Petit Marseillais. J&J, which just launched a roadshow for the IPO, is offering 151.2 million shares of common stock of Kenvue, that are priced between $20 and $23 per share. J&J said that it expects to grant the underwriters a 30-day choice to buy as much as a...
Continue reading